Latest news
Entropy Clears Ethics Hurdle for “World-First” Eight-Disorder Psychedelic Trial - KalkineKalkine · Wed, 05 Aug 2026 03:20:00 GMT72 patient multi-indication trial approved to fast track TRP-8803 commercialisation - The Manila TimesThe Manila Times · Tue, 04 Aug 2026 14:26:12 GMTEntropy Neurodynamics Secures Ethics Approval for 72-Patient, Eight-Indication TRP-8803 Basket Study - KalkineKalkine · Tue, 04 Aug 2026 03:54:05 GMTEntropy secures ethics approval for multi-indication trial - The AustralianThe Australian · Tue, 04 Aug 2026 03:31:00 GMTEntropy Neurodynamics (ASX:ENP): TRP-8803 Clinical Trial Advances - KalkineKalkine · Tue, 04 Aug 2026 00:44:00 GMTEntropy Neurodynamics advances TRP-8803 with 72 patient psychedelic therapy trial - BiotechDispatchBiotechDispatch · Tue, 04 Aug 2026 00:14:52 GMTEntropy Neurodynamics CEO to Present Clinical Progress and TRP-8803 Platform at TechKnow Invest Roadshow - KalkineKalkine · Mon, 27 Jul 2026 07:00:00 GMTEntropy Neurodynamics CEO to Present TRP-8803 Psilocin Programme at TechKnow Invest Roadshow - KalkineKalkine · Mon, 27 Jul 2026 07:00:00 GMT